Annual report
3645.TEDINET S100YYS4
Period2025-06-01 → 2026-05-31
Filed2026-08-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.7bn | 2025-06-01 → 2026-05-31 | Cons. | Net sales |
| Revenue | ¥6.1bn | 2024-06-01 → 2025-05-31 | Cons. | Net sales |
| Revenue | ¥5.3bn | 2023-06-01 → 2024-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.5bn | 2022-06-01 → 2023-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.7bn | 2021-06-01 → 2022-05-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥192m | 2025-06-01 → 2026-05-31 | Cons. | Operating income |
| Operating income | ¥99m | 2024-06-01 → 2025-05-31 | Cons. | Operating income |
| Ordinary income | ¥270m | 2025-06-01 → 2026-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥135m | 2024-06-01 → 2025-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥323m | 2023-06-01 → 2024-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥432m | 2022-06-01 → 2023-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥450m | 2021-06-01 → 2022-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥259m | 2025-06-01 → 2026-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥25m | 2024-06-01 → 2025-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥137m | 2025-06-01 → 2026-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥68m | 2024-06-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6m | 2023-06-01 → 2024-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥116m | 2022-06-01 → 2023-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥380m | 2021-06-01 → 2022-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥163m | 2025-06-01 → 2026-05-31 | Cons. | Profit loss |
| Net income | −¥38m | 2024-06-01 → 2025-05-31 | Cons. | Profit loss |
| Total assets | ¥4.6bn | at 2026-05-31 | Cons. | Assets |
| Total assets | ¥4.1bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥4.0bn | at 2024-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.5bn | at 2023-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2022-05-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.5bn | at 2026-05-31 | Cons. | Liabilities |
| Total liabilities | ¥2.3bn | at 2025-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.1bn | at 2026-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.8bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2024-05-31v | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.7bn | at 2022-05-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2026-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.9bn | at 2026-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-05-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-05-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.1bn | at 2022-05-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥99m | 2025-06-01 → 2026-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥81m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥120m | 2023-06-01 → 2024-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥429m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥343m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥87m | 2025-06-01 → 2026-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥260m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥285m | 2023-06-01 → 2024-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥62m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥355m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥291m | 2025-06-01 → 2026-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥219m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥144m | 2023-06-01 → 2024-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥18m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥282m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥14.96 | 2025-06-01 → 2026-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.64 | 2024-06-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.66 | 2023-06-01 → 2024-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.97 | 2022-06-01 → 2023-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.44 | 2021-06-01 → 2022-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥215.61 | at 2026-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥196.5 | at 2025-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥210.85 | at 2024-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥211.94 | at 2023-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥193.19 | at 2022-05-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 43.6% | at 2026-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.0% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.8% | at 2024-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.3% | at 2023-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2022-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.4% | 2025-06-01 → 2026-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -3.8% | 2024-06-01 → 2025-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 0.3% | 2023-06-01 → 2024-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2022-06-01 → 2023-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 25.8% | 2021-06-01 → 2022-05-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 290 | at 2026-05-31 | Cons. | Number of employees |
| Employees | 296 | at 2025-05-31 | Cons. | Number of employees |
| Employees | 274 | at 2024-05-31v | Cons. | Number of employees |
| Employees | 186 | at 2023-05-31v | Cons. | Number of employees |
| Employees | 163 | at 2022-05-31v | Cons. | Number of employees |
| Revenue | ¥1.9bn | 2025-06-01 → 2026-05-31 | Standalone | Net sales |
| Revenue | ¥2.1bn | 2024-06-01 → 2025-05-31 | Standalone | Net sales |
| Revenue | ¥2.1bn | 2023-06-01 → 2024-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.8bn | 2022-06-01 → 2023-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.6bn | 2021-06-01 → 2022-05-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥60m | 2025-06-01 → 2026-05-31 | Standalone | Operating income |
| Operating income | ¥148m | 2024-06-01 → 2025-05-31 | Standalone | Operating income |
| Ordinary income | ¥134m | 2025-06-01 → 2026-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥180m | 2024-06-01 → 2025-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥183m | 2023-06-01 → 2024-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥403m | 2022-06-01 → 2023-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥352m | 2021-06-01 → 2022-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥132m | 2025-06-01 → 2026-05-31 | Standalone | Income before income taxes |
| Profit before tax | −¥39m | 2024-06-01 → 2025-05-31 | Standalone | Income before income taxes |
| Net income | ¥79m | 2025-06-01 → 2026-05-31 | Standalone | Profit loss |
| Net income | −¥70m | 2024-06-01 → 2025-05-31 | Standalone | Profit loss |
| Net income | ¥81m | 2023-06-01 → 2024-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥214m | 2022-06-01 → 2023-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥248m | 2021-06-01 → 2022-05-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.3bn | at 2026-05-31 | Standalone | Assets |
| Total assets | ¥3.0bn | at 2025-05-31 | Standalone | Assets |
| Total assets | ¥3.1bn | at 2024-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.8bn | at 2023-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.5bn | at 2022-05-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.3bn | at 2026-05-31 | Standalone | Liabilities |
| Total liabilities | ¥1.2bn | at 2025-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.0bn | at 2026-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.8bn | at 2025-05-31 | Standalone | Net assets |
| Net assets / equity | ¥2.0bn | at 2024-05-31v | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.6bn | at 2022-05-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2026-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥768m | at 2025-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥8.6 | 2025-06-01 → 2026-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.87 | 2024-06-01 → 2025-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.98 | 2023-06-01 → 2024-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.89 | 2022-06-01 → 2023-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.4 | 2021-06-01 → 2022-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥3 | 2025-06-01 → 2026-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2024-06-01 → 2025-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2023-06-01 → 2024-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥2.5 | 2022-06-01 → 2023-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2021-06-01 → 2022-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥212.86 | at 2026-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥201.8 | at 2025-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥216.43 | at 2024-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥209.76 | at 2023-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥181.56 | at 2022-05-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 59.9% | at 2026-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2025-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.9% | at 2024-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2023-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.3% | at 2022-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.2% | 2025-06-01 → 2026-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -3.8% | 2024-06-01 → 2025-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.2% | 2023-06-01 → 2024-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2022-06-01 → 2023-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.3% | 2021-06-01 → 2022-05-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,773,000 | at 2026-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2025-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2024-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2023-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2022-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 135 | at 2026-05-31 | Standalone | Number of employees |
| Employees | 134 | at 2025-05-31 | Standalone | Number of employees |
| Employees | 121 | at 2024-05-31v | Standalone | Number of employees |
| Employees | 114 | at 2023-05-31v | Standalone | Number of employees |
| Employees | 98 | at 2022-05-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 95
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-06-01 → 2026-05-31 | ¥290,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-06-01 → 2026-05-31 | ¥290,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-06-01 → 2026-05-31 | ¥290,000 |
| Cloud Integrationreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥700,000 |
| Cloud Integrationreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥3m |
| Cloud Integrationreportable segment | employees | at 2026-05-31 | 51 pure |
| Cloud Integrationreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥379m |
| Cloud Integrationreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥379m |
| Cloud Integrationreportable segment | segment assets | at 2026-05-31 | ¥814m |
| Cloud Integrationreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥50m |
| Mediaplatformreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥4m |
| Mediaplatformreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥1m |
| Mediaplatformreportable segment | employees | at 2026-05-31 | 28 pure |
| Mediaplatformreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥975m |
| Mediaplatformreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥975m |
| Mediaplatformreportable segment | segment assets | at 2026-05-31 | ¥137m |
| Mediaplatformreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥463m |
| Medical B To Breportable segment | capex | 2025-06-01 → 2026-05-31 | ¥6m |
| Medical B To Breportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥3m |
| Medical B To Breportable segment | employees | at 2026-05-31 | 13 pure |
| Medical B To Breportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥182m |
| Medical B To Breportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥178m |
| Medical B To Breportable segment | revenue intersegment | 2025-06-01 → 2026-05-31 | ¥3m |
| Medical B To Breportable segment | segment assets | at 2026-05-31 | ¥67m |
| Medical B To Breportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥42m |
| Medical Institution Management Supportreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥4m |
| Medical Institution Management Supportreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥19m |
| Medical Institution Management Supportreportable segment | employees | at 2026-05-31 | 169 pure |
| Medical Institution Management Supportreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥5.2bn |
| Medical Institution Management Supportreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥5.2bn |
| Medical Institution Management Supportreportable segment | revenue intersegment | 2025-06-01 → 2026-05-31 | ¥97,000 |
| Medical Institution Management Supportreportable segment | segment assets | at 2026-05-31 | ¥2.0bn |
| Medical Institution Management Supportreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥122m |
| —segment total | capex | 2025-06-01 → 2026-05-31 | ¥14m |
| —segment total | depreciation | 2025-06-01 → 2026-05-31 | ¥26m |
| —segment total | revenue | 2025-06-01 → 2026-05-31 | ¥6.7bn |
| —segment total | revenue external | 2025-06-01 → 2026-05-31 | ¥6.7bn |
| —segment total | revenue intersegment | 2025-06-01 → 2026-05-31 | ¥3m |
| —segment total | segment assets | at 2026-05-31 | ¥3.0bn |
| —segment total | segment profit | 2025-06-01 → 2026-05-31 | ¥677m |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-06-01 → 2026-05-31 | ¥14m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-06-01 → 2026-05-31 | ¥26m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-06-01 → 2026-05-31 | ¥6.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-06-01 → 2026-05-31 | ¥6.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-06-01 → 2026-05-31 | ¥3m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-05-31 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-06-01 → 2026-05-31 | ¥678m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-06-01 → 2025-05-31 | ¥998,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-06-01 → 2025-05-31 | ¥998,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-06-01 → 2025-05-31 | ¥998,000 |
| Cloud Integrationreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥4m |
| Cloud Integrationreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥375m |
| Cloud Integrationreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥375m |
| Cloud Integrationreportable segment | segment assets | at 2025-05-31 | ¥751m |
| Cloud Integrationreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥34m |
| Mediaplatformreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥2m |
| Mediaplatformreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥1.1bn |
| Mediaplatformreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥1.1bn |
| Mediaplatformreportable segment | segment assets | at 2025-05-31 | ¥126m |
| Mediaplatformreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥542m |
| Medical B To Breportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥1m |
| Medical B To Breportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥158m |
| Medical B To Breportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥158m |
| Medical B To Breportable segment | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥300,000 |
| Medical B To Breportable segment | segment assets | at 2025-05-31 | ¥29m |
| Medical B To Breportable segment | segment profit | 2024-06-01 → 2025-05-31 | −¥14m |
| Medical Institution Management Supportreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥22m |
| Medical Institution Management Supportreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥19m |
| Medical Institution Management Supportreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥4.4bn |
| Medical Institution Management Supportreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥4.4bn |
| Medical Institution Management Supportreportable segment | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥29,000 |
| Medical Institution Management Supportreportable segment | segment assets | at 2025-05-31 | ¥1.9bn |
| Medical Institution Management Supportreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥190m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥121m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥3m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥41m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥41m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | segment profit | 2024-06-01 → 2025-05-31 | −¥154m |
| —segment total | capex | 2024-06-01 → 2025-05-31 | ¥143m |
| —segment total | depreciation | 2024-06-01 → 2025-05-31 | ¥29m |
| —segment total | revenue | 2024-06-01 → 2025-05-31 | ¥6.1bn |
| —segment total | revenue external | 2024-06-01 → 2025-05-31 | ¥6.1bn |
| —segment total | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥329,000 |
| —segment total | segment assets | at 2025-05-31 | ¥2.8bn |
| —segment total | segment profit | 2024-06-01 → 2025-05-31 | ¥597m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-06-01 → 2025-05-31 | ¥143m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-06-01 → 2025-05-31 | ¥29m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-06-01 → 2025-05-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-06-01 → 2025-05-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥329,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-05-31 | ¥2.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-06-01 → 2025-05-31 | ¥598m |
| Mediaplatformreportable segment | employees | at 2026-05-31 | 28 pure |
| Medical B To Breportable segment | employees | at 2026-05-31 | 13 pure |
| Medical Institution Management Supportreportable segment | employees | at 2026-05-31 | 65 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,476
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.0958 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 783460 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.0847 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 594760 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0643 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 538600 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0582 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 322400 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0348 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 287300 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0310 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 107800 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0116 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 100000 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0108 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 93720 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0101 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 91020 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0098 | |
| Number of shares held | CurrentYearInstant | 3805520 | |
| Shareholding ratio | CurrentYearInstant | 0.4115 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 1526000 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 9238300 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 92383 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 8700 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 10773000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 92383 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 1526000 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 1526000 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.1417 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 1526000 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 1526000 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.1417 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 27740000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 3.0 | |
| Number of male directors and other officers | FilingDateInstant | 7 | |
| Number of female directors and other officers | FilingDateInstant | 2 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.22 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E24982-000HirakawaDaiMember | 886460 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E24982-000HirakawaYujiMember | 783460 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E24982-000HayakwaRyusukeMember | 594760 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E24982-000KatoHiroakiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E24982-000SugawaraSokoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E24982-000MinowaKeiichiMember | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |